Public and Patients
- About Us
- Cancer Information
- Clinical Trials
- Events & Outreach
- Make a Gift
- News & Feature Stories
- Survivorship
Researchers and Staff
Cancer Center Update
November 22, 2005
Cancer Center Update is sent to Cancer Center members and staff every Tuesday at 10 a.m. To submit an item for publication, send the information to Sandi Sherman by noon the Friday before publication.
In This Issue:
Professional Education and Seminars
Grant Information & Announcements
Telomerase inhibition and osseous androgen independent prostate cancer
Kenneth Koeneman, M.D., Dougherty Endowed Chair in Urologic Oncology, Director, Center for Prostate Cancer, Department of Urology, University of Minnesota
A peek at next week’s seminar:
How do T cells activate integrins?
Yoji Shimizu, Ph.D., Professor, Department of Laboratory Medicine and Pathology, Program Leader, Cancer Center Immunology Program, University of Minnesota
For a complete schedule visit: http://www.cancer.umn.edu/page/aboutus/date.html
MICAB SEMINAR
Monday, November 28, 2005, 12:00 – 1:00 p.m., 2-620 Moos Tower
p53-NF-kB relationship in cancer and normal tissues
Andrei Gudkov, Ph.D., D.Sci., Professor, Chairman, Department of Molecular Genetics and Virology, Lerner Research Institute, Cleveland Clinic.
SCHOOL OF NURSING SEMINAR
Wednesday, November 30, 2005, 2:00 p.m., 4-180 Weaver-Densford
Women’s Work: Experiencing the First Weeks After Breast Cancer Diagnosis
Robin Lally, PhD, RN, Graduate Instructor, School of Nursing, Breast Cancer Clinical Nurse Specialist, Park Nicollet Health Services
Robin is a candidate for a tenure track position in Adult Health in the School of Nursing.
NOVEMBER 30 DEADLINE FOR ENROLLING IN MEDICAL AND DENTAL COVERAGE
New medical plans and rate structures mean that everyone will need to make an election for medical and dental coverage during Open Enrollment. Employees will also be able to enroll in a flexible spending account, and add or increase long-term disability insurance coverage. Open Enrollment will take place from November 1 to November 30. Current employees will enroll on line using Employee Self-Service (AFSCME bargaining unit employees will enroll at a later date to be announced). Information about the new medical plan options and dental plan options can be viewed at http://www1.umn.edu/ohr/eb/uplan/openenroll/index.html .
SMALL GRANTS FOR BEHAVIORAL RESEARCH IN CANCER CONTROL (R03)
NCI (PAR-06-073)
Application Receipt Dates: April 20, 2006; August 21, 2006; December 22, 2006; April 20, 2007; August 22, 2007; December 20, 2007; April 20, 2008; August 21, 2008; December 22, 2008
The objective of the NCI Small Grants Program for Behavioral Research in Cancer Control is to provide support for new investigators or established scientists refocusing their research interests to behavioral research in cancer control. The award provides support for pilot or feasibility studies projects, development and testing of new methodologies, development and testing of new research technology, secondary analysis of existing data, self-contained research projects, or innovative studies that provide a basis for more extended research. This funding opportunity uses the NIH small grants (R03) award mechanism. The total budget may not exceed $100,000 in direct costs for the entire project. The direct costs in any one year must not exceed $50,000. The total project period for applications submitted in response to this announcement may not exceed 3 years. To view the entire announcement, see
http://grants.nih.gov/grants/guide/pa-files/PAR-06-073.html.
The Grant Opportunities web page is currently under construction. To view a list of cancer research funding resources and links to their web sites visit http://www.cancer.umn.edu/page/aboutus/grantopp.html .
BMT CONFERENCE
Monday, November 28, 2005, 1:15-2:15 p.m., 450 CCRB
ASH Presentations:
Non-Myeloablative (NMA) Umbilical Cord Blood Transplantation (UCBT): Promising Disease-Free Survival on 95 Consecutive Patients"
Claudio Brunstein, MD — Assistant Professor, Medicine HOT
Prolonged Remissions with Autologous and Allogeneic Stem Cell Transplantation for Burkitt's Lymphoma: Long Term Follow-Up at a Single Institution
Purvi Gada, M.B., B.S., Medicine HOT Fellow
Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Acute Lymphocytic Leukemia in 126 Adults: Impact of Donor Source on Leukemia Free Survival
Priya Kumar, M.D., Medicine HOT Fellow
For a complete schedule visit http://www.cancer.umn.edu/page/aboutus/bmtlect.html
REMINDERS
MARK YOUR CALENDARS FOR THE CANCER CENTER HOLIDAY EVENT DECEMBER 7!
This year's Cancer Center Holiday event will take place from 5:00 to 7:00 p.m., Wednesday, December 7 in the West Wing of the Campus Club. Appetizers, beverages and live entertainment will be provided.
DAMON RUNYON CANCER RESEARCH FOUNDATION SCHOLAR AWARD
The Damon Runyon Cancer Research Foundation is offering Scholar Awards to support the development of outstanding scientists as they establish their own independent research laboratories. Assistant Professors in the first three years of their appointment who do not have another career development award are eligible to apply. The applicant's scientific accomplishments must show promise of future contributions that will lead to understanding the causes and mechanisms of cancer and to developing more effective cancer therapies and preventions. This is a three-year award for $100,000 per year. A total of five projects will be awarded.
Two nominations are permitted per institution (one basic scientist and one physician-scientist [MD or MD/PhD affiliated with a clinical department]), plus an unlimited number of applications by former Damon Runyon Fellows. Potential applicants should submit a preliminary proposal of 1-2 pages in length plus a curriculum vitae. If there are multiple applicants/nominations, a sub committee of the Masonic Cancer Center 's Executive Committee will screen applications/nominations and select the 2 finalists. Nominating materials should be sent via e-mail to Mary Sumpmann (sumpm001@umn.edu) before December 19th, 2005.
Questions should be addressed to Mark Paller, Assistant Vice President for Research, AHC (palle001@umn.edu). For more information visit the Damon Runyon Cancer Research Fund web site at www.drcrf.org/apScholar.html.